每日维生素B3补充在高风险退伍军人中将非黑瘤皮肤癌复发率减少54%。 A daily vitamin B3 supplement cut non-melanoma skin cancer recurrence by 54% in high-risk veterans.

对JAMA皮肤学的一项新研究发现,在近34 000名有皮肤癌史的退伍军人中,至少一个月每天服用500毫克尼古丁胺(维生素B3)两次将非蛋白瘤皮肤癌复发的风险降低54%。 A new study in JAMA Dermatology found that taking 500mg of nicotinamide (Vitamin B3) twice daily for at least one month reduced the risk of non-melanoma skin cancer recurrence by 54% among nearly 34,000 veterans with a history of skin cancer. 所有参与者的总体风险降低率约为14%,降幅最大的是典型细胞癌。 The overall risk reduction across all participants was about 14%, with the greatest benefit seen in squamous cell carcinoma. 研究人员建议,该补编可广泛获得,其副作用微乎其微,应定期推荐用于二级预防,特别是在诊断后早期开始时。 Researchers suggest the supplement, which is widely available and has minimal side effects, should be routinely recommended for secondary prevention, especially when started early after diagnosis. 需要对其对未事先进行皮肤癌诊断的人的影响或对乳腺瘤风险的影响开展更多的研究。 More research is needed on its effects for people without a prior skin cancer diagnosis or on melanoma risk.